Versant Ventures strengthens Canadian investment team
U.S. life sciences venture capital firm Versant Ventures had announced promotions in its investment team. They include the promotion of Vancouver-based Jerel Davis to managing director. Davis, who joined Versant in 2011, will be responsible for continuing to build the firm's portfolio and market presence in Canada and North America. Versant also announced that Blueline Bioscience, its Toronto-based biotechnology incubator, has appointed Mary Haak-Frendscho as CEO.
12 April 2016•5 mins read
